Filing Details
- Accession Number:
- 0001596783-17-000098
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-03 17:31:22
- Reporting Period:
- 2017-08-01
- Filing Date:
- 2017-08-03
- Accepted Time:
- 2017-08-03 17:31:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1684273 | Christine Dolan | C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | Svp - Product Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-01 | 745 | $34.85 | 14,058 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2017 in order to implement a plan of financial diversification.
- Includes restricted stock units.
Billionaire Hedge Funds
